Helsinn Group

Helsinn is a global pharmaceutical company that builds, manufactures, launches, and commercializes products to improve the quality of life for patients with cancer and chronic disease, with a focus on supportive care, oncology, and dermato-oncology. Founded in 1976, Helsinn has 50 years of experience in the pharmaceutical industry, with an extensive network of long-standing trusted partners enabling a commercial presence in about 90 countries. Headquartered in Lugano, Switzerland, Helsinn Healthcare SA defines and implements the Group’s strategy, overseeing its three subsidiaries: Helsinn Birex Pharmaceuticals Ltd.(Ireland), Helsinn Therapeutics (U.S.), Inc, and Helsinn Pharmaceuticals (Beijing) Co, Ltd. Our mission is to champion and support patients with cancer and chronic diseases at every stage of their journey, by providing them with the best medications and solutions based on their needs and preferences. Follow us to stay informed about the latest news from Helsinn Group. Interested in joining our team? Visit and explore the “Careers – Join us” section to apply via the appropriate country portal.* This account shall only be used to share news concerning Helsinn. We would like to emphasize that due to the highly regulated nature of the pharma industry, we cannot engage with you online in any discussions concerning our or other companies’ products and/or services, and/or treatment options. It is best to hold such discussions and to seek guidance privately from your healthcare professional.